Brokerage firms remain divided on Zydus Lifesciences as the company announced to acquire France-based Amplitude Surgical for ...

India still relies largely on imported devices and implants, when it comes to MedTech. This offers us a great opportunity to ...

Zydus will focus on state-of-the-art manufacturing capabilities that will enable high quality solutions for patients with cutting-edge research and innovation, reports Financial Express.

India's Zydus Lifesciences is set to acquire an 85.6% stake in France's Amplitude Surgical for nearly $280 million to expand ...

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...

The claim that exercise and diet do not impact lifespan is false. Scientific evidence strongly supports the role of diet and ...

The discussions emphasised the evolving landscape of acute liver failure, sepsis in chronic liver disease, and post-transplant critical care The Tribune, now published from Chandigarh, started ...

The Quadrivalent Inactivated Influenza Vaccine has been developed at Zydus' Vaccine Technology Centre (VTC) in Ahmedabad, a facility known for its expertise in vaccine research, development, and ...

Zydus Lifesciences on Wednesday said it is introducing a vaccine for protection against a new strain of influenza virus. The company is introducing the country’s first flu protection quadrivalent ...

(Image Credits: Freepik) Zydus on Wednesday announced that it ... has been developed at the Vaccine Technology Centre (VTC) in Ahmedabad which has proven capabilities in researching, developing ...